Design, synthesis and pharmacological evaluation of original nitrobenzenesulfonylureas and sulfonylcyanoguanidines as thromboxane A2 receptor antagonists/Conception, synthèse et évaluation pharmacologique de nitrobenzènesulfonylurées et sulfonylcyanoguanidines en tant qu'antagonistes des récepteurs au thromboxane A2
Thromboxane A2 (TXA2) is an important mediator metabolized from arachidonic acid through the cyclooxygenase pathway, mainly in platelets and macrophages. It is a potent inducer of platelet aggregation and smooth muscle contraction. Its overproduction has been detected in pathologies such as stroke,...
Main Author: | Hanson, Julien |
---|---|
Other Authors: | Offermanns, Stephan |
Format: | Others |
Published: |
Universite de Liege
2007
|
Subjects: | |
Online Access: | http://bictel.ulg.ac.be/ETD-db/collection/available/ULgetd-10092007-173228/ |
Similar Items
-
NTP42, a novel antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension
by: Eamon P. Mulvaney, et al.
Published: (2020-04-01) -
Effects of KP-496, a Novel Dual Antagonist for Leukotriene D4 and Thromboxane A2 Receptors, on Contractions Induced by Various Agonists in the Guinea Pig Trachea
by: Masakazu Ishimura, et al.
Published: (2006-01-01) -
Podocytopenia in Diabetic Nephropathy: A Role for the Thromboxane A2 TP Receptor
by: Bugnot, Gwendoline Carine Denise
Published: (2013) -
Podocytopenia in Diabetic Nephropathy: A Role for the Thromboxane A2 TP Receptor
by: Bugnot, Gwendoline Carine Denise
Published: (2013) -
Stability of thromboxane in blood samples
by: Helgadóttir H, et al.
Published: (2019-06-01)